HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CBD Supplements Safety: EU Two Years Behind UK

Executive Summary

When it comes to assessing the safety of CBD in foods, the EU appears to be lagging behind the UK. Food Standards Agency CEO Emily Miles has noted that EFSA recently reached the same conclusions as the UK’s Committee on Toxicity did two years ago: there are still evidence gaps relating to CBD as a food. This may reassure UK operators that with the FSA further along in the assessment process it will not follow EFSA in suspending CBD novel food applications - but as expert Greer Deal notes, it's too soon to say. 

You may also be interested in...

EU CBD Novel Food Applications On Hold As EFSA Considers Health Risks

All European Union CBD novel food applications have been paused by EFSA after its Panel on Nutrition, Novel Foods and Food Allergens raised concerns about the ingredient's safety, pointing in a wide-ranging scientific literature review to a number of data gaps related to bioavailability, liver damage, gastrointestinal issues and possible negative impacts on pregnancy and reproductive health.  

UK FSA Adds More CBD Products To List, Some ‘Removed,’ As Regulatory Chaos Continues

The UK’s Food Standards Agency has added almost 2,500 products to its recently published cannabidiol list, and “removed” 34, meaning that they must be withdrawn from retail shelves immediately. Confusion remains, however, with the regulator's  shadowy "active application" category conflicting with its advice to enforcers to start clamping down not just on products marked "removed" but also products not on the list.

UK FSA Admits It Could Have ‘Better Anticipated’ CBD Application Bottleneck

In a report to a forthcoming board meeting, UK FSA policy head Rebecca Sudworth acknowledges that the agency could have “better anticipated” the surge in cannabidiol applications received just before the 31 March 2021 deadline.

Related Content


Latest News



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts